Skip to main content
Springer logoLink to Springer
. 2015 May 27;30(6):521–523. doi: 10.1007/s10654-015-0035-4

Erratum to: Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example

Nicholas J Wald 1,, Joan K Morris 1
PMCID: PMC4643548  PMID: 26013360

Erratum to: Eur J Epidemiol (2014) 29:605–612 DOI 10.1007/s10654-014-9932-1

Computing errors in our paper introduced small errors. We here provide the corrected estimates together with correct versions of the six tables (Tables 1, 2, 3, 5, 6, 7) that contained errors (available on the journal website linked to this paper). The authors apologize for the inconvenience caused by the following errors.

Table 1.

Estimates relating to the prevention of a first myocardial infarction (MI) or stroke (“disorder”) in people taking polypill from specified ages

Taking polypill from specified age to age 99 Proportion of people who will have first MI or stroke in the absence of treatment (%) Proportion of people who will have first MI or stroke while taking polypill (%) Relative risk reduction (%) Absolute annual risk reduction (%) Proportion of people who benefit (HBp) (%) Among those who benefit: Average years of life gained without an MI or stroke (HBag)
50 34 16 53 0.53 34 7.7
60 33 16 52 0.69 33 6.5
70 32 16 51 0.95 32 5.1
80 29 15 49 1.41 29 3.4

Table 2.

Estimates relating to the prevention of a first myocardial infarction (MI) or stroke in individuals aged 50 and above according to specified daily salt reduction

Salt reduction (g/day) Proportion of people who will have first MI or stroke in the absence of treatment (%) Proportion of people who will have first MI or stroke with a reduced salt intake (%) Relative risk reduction (%) Absolute annual risk reduction (%) Proportion of people who benefit (HBp) (%) Among those who benefit: average years of life gained without an MI or stroke (HBag)
1.5 34 32 4 0.04 34 0.7
3.0 34 31 8 0.09 34 1.4
4.5 34 30 12 0.13 34 2.0
6.0 34 28 16 0.17 34 2.6

Table 3.

The two measures of health benefit in people aged 50 and over according to different preventive interventions to reduce the risk of a first myocardial infarction (MI) or stroke

Reducing salt by 6 g/day Taking simvastatin 20 mg daily from age 50 Taking three blood-pressure-lowering drugs at half standard dose daily from age 50 Taking polypill daily from age 50 (all four drugs) Reducing salt by 6 g/day and taking polypill daily from age 50
Proportion who benefit (HBp) 34 % 34 % 34 % 34 % 34 %
Among these: average years of life gained without an MI or stroke (HBag) 2.6 3.7 5.5 7.7 8.7

Table 5.

Age-specific relative risk estimates

Age taking polypill Relative risk of a first stroke on daily polypilla Relative risk of a first myocardial infarction on daily polypilla
50 0.26 0.13
60 0.28 0.23
70 0.34 0.32
80 0.44 0.36
90+ 0.51 0.38

aPolypill contained amlodipine 2.5 mg, losartan 25 mg, hydrochlorothiazide 12.5 mg and simvastatin 20 mg

Table 6.

Average relative risk reductions (%) of a first myocardial infarction or stroke according to age at starting polypill and years of follow-up

Years of follow-up Age starting to take polypill daily
50 60 70 80
10 78 71 63 54
20 73 64 55 49
30 66 57 51
40 58 52
50 53

Table 7.

Reduction in systolic blood pressure (SBP) and age-specific relative risk estimates of a first myocardial infarct (MI) or stroke according to age and salt intake reduction

Age 1.5 g/day 3.0 g/day 4.5 g/day 6 g/day
SBP reduction (mmHg) Relative risk of a first MI Relative risk of a first stroke SBP reduction (mmHg) Relative risk of a first MI Relative risk of a first stroke SBP reduction (mmHg) Relative risk of a first MI Relative risk of a first stroke SBP reduction (mmHg) Relative risk of a first MI Relative risk of a first stroke
45 1.7 0.93 0.91 3.3 0.87 0.83 4.9 0.82 0.75 6.6 0.76 0.69
55 2.3 0.92 0.88 4.6 0.85 0.77 6.9 0.79 0.67 9.2 0.73 0.60
65 2.6 0.94 0.90 5.2 0.88 0.82 7.7 0.82 0.74 10.3 0.77 0.67
75 2.7 0.95 0.92 5.4 0.90 0.85 8.1 0.85 0.78 10.8 0.81 0.72
85 2.7 0.96 0.95 5.5 0.92 0.90 8.2 0.89 0.86 11.0 0.85 0.82

Abstract

Under the holistic model, 34 % (not 33 %) of people who take the polypill from age 50 benefit, gaining on average 7.7 (not 8.0) years of life without an MI or stroke (18 % benefit under the reductionist model—not 19 %). Estimates for reducing salt intake by 6 g/day are 34 % and 2.6 years, respectively, (not 33 % and 2.8 years) under the holistic model and 5 % (not 6 %) under the reductionist model.

Results

Para 1: 56 % should read 53 %. 0.37 % should read 0.53 %. 33 % should read 34 %. 8.0 years should read 7.7 years. 67 % should read 66 %.

Para 2: 33 % should read 34 %, 8.0 years should read 7.7 years.

Para 3: 33 % should read 34 %.

Para 4: 33 % should read 34 %, 2.8 years should read 2.6 years and 8.8 years should read 8.7 years.

Discussion

Para 2: 19 % should read 18 %, 33 % should read 34 %, 15 % should read 16 %, 8.0 should read 7.7.

Para 3: 33 % should read 34 %, 2.8 years should read 2.6 years, 6 % should read 5 %.

Para 4: 81 % should read 78 %, 55 % should read 54 %, 1.0 % should read 1.33 %.

Para 5: 33 % should read 34 %, 50 % should read 46 %.

Appendix

Section 2: Estimating the age specific relative risk of a myocardial infarction or stroke on the Polypill.

Para 2: 56 % should read 53 %, 81 % should read 78 %.

Footnotes

The online version of the original article can be found under doi:10.1007/s10654-014-9932-1.


Articles from European Journal of Epidemiology are provided here courtesy of Springer

RESOURCES